Results 31 to 40 of about 4,259,087 (330)

A possible link to uracil DNA glycosylase in the synergistic action of HDAC inhibitors and thymidylate synthase inhibitors

open access: yesJournal of Translational Medicine, 2020
It is well established that thymidylate synthase inhibitors can cause cellular toxicity through uracil DNA glycosylase (UNG2)-dependent pathways. Additionally, thymidylate synthase inhibitors and HDAC inhibitors are known to act synergistically in a ...
Meredith S. Showler, Brian P. Weiser
doaj   +1 more source

Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds

open access: yesPharmaceuticals, 2023
Histone deacetylases (HDAC) represent promising epigenetic targets for several diseases including different cancer types. The HDAC inhibitors approved to date are pan-HDAC inhibitors and most show a poor selectivity profile, side effects, and in ...
Emre F. Bülbül   +7 more
doaj   +1 more source

Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents

open access: yesMolecules, 2015
Histone dacetylases (HDACs) are a group of enzymes that remove acetyl groups from histones and regulate expression of tumor suppressor genes. They are implicated in many human diseases, especially cancer, making them a promising therapeutic target for ...
Madhusoodanan Mottamal   +3 more
doaj   +1 more source

Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3 [PDF]

open access: yes, 2012
The 5-lipoxygenase (5-LO) is the key enzyme in the formation of leukotrienes. We have previously shown that the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) activates 5-LO transcription via recruitment of Sp1, Sp3 and RNA polymerase II to ...
Julia Metzner   +13 more
core   +1 more source

New kinase and HDAC hybrid inhibitors: recent advances and perspectives - Anonimysed Supplementary Material.docx

open access: yes, 2022
   Table S1. Hybrid RTK/HDAC inhibitors (1-19) developed in the last years.     Table S2. Hybrid non-receptor TK/HDAC inhibitors 20 28) developed in the last years.    Table S3. Hybrid SK/HDAC inhibitors (29-39) developed in the last years.
Karoline B. Waitman (10351881)   +1 more
core   +1 more source

HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.

open access: yesJournal of Clinical Investigation, 2020
The Warburg effect is a tumor related phenomenon that may be targeted therapeutically. Here, we showed that glioblastoma cultures and patient tumors harbored super-enhancers in several genes related to the Warburg effect.
T. Nguyen   +18 more
semanticscholar   +1 more source

HDACs and HDAC inhibitors in colon cancer [PDF]

open access: yesEpigenetics, 2008
The histone deacetylase (HDAC) family of transcriptional co-repressors have emerged as important regulators of colon cell maturation and transformation. Pharmacological inhibitors of class I and II HDAC activity (HDACi) are potent inducers of growth arrest, differentiation and apoptosis of colon cancer cells in vitro and in vivo, implicating a role for
openaire   +2 more sources

HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents [PDF]

open access: yes, 2014
The NRF2 signalling cascade provides a primary response against electrophilic chemicals and oxidative stress. The activation of NRF2-signaling is anticipated to have adverse clinical consequences; NRF2 is activated in a number of cancers, additionally ...
A Kenneth MacLeod   +17 more
core   +2 more sources

Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors

open access: yesMolecules, 2023
Multi-target drugs (MTDs) are emerging alternatives to combination therapies. Since both histone deacetylases (HDACs) and cyclooxygenase-2 (COX-2) are known to be overexpressed in several cancer types, we herein report the design, synthesis, and ...
Luisa M. Bachmann   +7 more
doaj   +1 more source

Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function

open access: yesFrontiers in Immunology, 2018
Histone deacetylases (HDAC) are one of the key epigenetic modifiers that control chromatin accessibility and gene expression. Their role in tumorigenesis is well established and HDAC inhibitors have emerged as an effective treatment modality.
Sajad A. Bhat   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy